Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
University College Cork
Rutgers, The State University of New Jersey
University Hospital Tuebingen
National Institutes of Health Clinical Center (CC)
University of Nebraska
Dana-Farber Cancer Institute
Vastra Gotaland Region
National Institutes of Health Clinical Center (CC)
University Health Network, Toronto
Mayo Clinic
The Netherlands Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Travera Inc
Washington University School of Medicine
Fudan University
Jonsson Comprehensive Cancer Center
Hospital Israelita Albert Einstein
West China Hospital
UNICANCER
MedSIR
Instituto do Cancer do Estado de São Paulo
German Cancer Research Center
Sun Yat-sen University
Institute of Cancer Research, United Kingdom
UNICANCER
Fudan University
Shanghai Bovax Biotechnology Co., Ltd.
Travera Inc
The Netherlands Cancer Institute
University of Maryland, College Park
Universitaire Ziekenhuizen KU Leuven
The Affiliated Hospital of Qingdao University
SCG Cell Therapy Pte. Ltd.
University Medical Center Groningen
Shanghai Bovax Biotechnology Co., Ltd.
Oslo University Hospital
University of Maryland, College Park
Latin American Cooperative Oncology Group
UNICANCER
HRYZ Biotech Co.
Deciphera Pharmaceuticals, LLC
Dana-Farber Cancer Institute
The Affiliated Hospital of Qingdao University
A.O.U. Città della Salute e della Scienza
Centre Hospitalier Universitaire de Besancon